Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M De Jonge

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2025
Phase Ib and dose-expansion study of GSK3326595, a PRMT5 inhibitor as monotherapy and in combination with pembrolizumab in patients with advanced cancersM M Gounder, P Martin-Romano, A Italiano, et al.
Journal of the National Cancer Institute|March 12, 2021
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort StudyMarthe M de Jonge, Cornelis D de Kroon, Denise J Jenner, et al.
Trials|January 17, 2024
Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trialAnna E C Stoelinga, Maarten E Tushuizen, Wilbert B van den Hout, et al.
Journal of Hepatology|December 15, 2023
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitisRomée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
Trials|December 13, 2022
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trialRomée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
Blood Advances|August 8, 2023
A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphomaDiede A G van Bladel, Wendy B C Stevens, Leonie I Kroeze, et al.
JHEP Reports : Innovation in Hepatology|August 8, 2024
Incidence and prevalence of primary biliary cholangitis in the Netherlands - A nationwide cohort studyRozanne C de Veer, Maria C B van Hooff, Ellen Werner, et al.
Alimentary Pharmacology & Therapeutics|April 14, 2026
A Nationwide Assessment of Anticholestatic Therapy Uptake in Patients With Primary Biliary Cholangitis: Opportunities for OptimisationEllen Werner, Maria C B van Hooff, Gemma H X Weijsters, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2025
Phase Ib and dose-expansion study of GSK3326595, a PRMT5 inhibitor as monotherapy and in combination with pembrolizumab in patients with advanced cancersM M Gounder, P Martin-Romano, A Italiano, et al.
Journal of the National Cancer Institute|March 12, 2021
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort StudyMarthe M de Jonge, Cornelis D de Kroon, Denise J Jenner, et al.
Trials|January 17, 2024
Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trialAnna E C Stoelinga, Maarten E Tushuizen, Wilbert B van den Hout, et al.
Journal of Hepatology|December 15, 2023
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitisRomée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
Trials|December 13, 2022
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trialRomée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
Blood Advances|August 8, 2023
A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphomaDiede A G van Bladel, Wendy B C Stevens, Leonie I Kroeze, et al.
JHEP Reports : Innovation in Hepatology|August 8, 2024
Incidence and prevalence of primary biliary cholangitis in the Netherlands - A nationwide cohort studyRozanne C de Veer, Maria C B van Hooff, Ellen Werner, et al.
Alimentary Pharmacology & Therapeutics|April 14, 2026
A Nationwide Assessment of Anticholestatic Therapy Uptake in Patients With Primary Biliary Cholangitis: Opportunities for OptimisationEllen Werner, Maria C B van Hooff, Gemma H X Weijsters, et al.
Pageof 16